ACHIEVE-PEDS

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

OrforglipronOngoingNot yet recruitingPhase 3Open NCT07668336 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…